Breakdown | ||||
Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 |
---|---|---|---|---|
Income Statement | Total Revenue | |||
17.76B | 15.29B | 14.71B | 14.13B | 13.41B |
Gross Profit | ||||
2.02B | 1.65B | 1.22B | 1.05B | 1.03B |
EBIT | ||||
0.00 | 1.00B | 859.00M | 827.00M | 645.00M |
EBITDA | ||||
2.25B | 1.54B | 1.66B | 1.29B | 974.00M |
Net Income Common Stockholders | ||||
1.07B | 658.00M | 927.00M | 586.00M | 241.00M |
Balance Sheet | Cash, Cash Equivalents and Short-Term Investments | |||
2.56B | 2.41B | 1.51B | 2.48B | 2.21B |
Total Assets | ||||
33.67B | 30.69B | 28.58B | 28.38B | 27.07B |
Total Debt | ||||
4.70B | 4.93B | 4.61B | 5.67B | 5.70B |
Net Debt | ||||
2.14B | 2.52B | 3.10B | 3.19B | 3.49B |
Total Liabilities | ||||
23.47B | 22.13B | 20.53B | 21.54B | 21.44B |
Stockholders Equity | ||||
8.99B | 7.80B | 7.18B | 6.43B | 5.27B |
Cash Flow | Free Cash Flow | |||
646.00M | 404.00M | 523.00M | 190.00M | -36.00M |
Operating Cash Flow | ||||
1.54B | 1.19B | 1.28B | 805.00M | 275.00M |
Investing Cash Flow | ||||
-753.00M | -262.00M | -924.00M | -604.00M | -438.00M |
Financing Cash Flow | ||||
-678.00M | -12.00M | -1.40B | 30.00M | 460.00M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
---|---|---|---|---|---|---|---|
77 Outperform | €3.59B | 18.25 | 11.69% | 2.24% | 18.70% | ― | |
75 Outperform | €30.56B | 29.11 | 12.77% | 0.52% | 16.17% | 63.09% | |
73 Outperform | €535.68M | 87.38 | 2.02% | 0.71% | 38.67% | -6.16% | |
71 Outperform | €16.87B | 23.83 | 15.32% | 1.37% | 20.34% | 25.32% | |
68 Neutral | €5.95B | 12.47 | 1.92% | -7.61% | 62.12% | ||
66 Neutral | $4.48B | 12.26 | 5.32% | 248.53% | 4.10% | -12.36% | |
64 Neutral | €5.20B | ― | ― | ― | ― |